vs
Side-by-side financial comparison of BingEx Ltd (FLX) and MEDIFAST INC (MED). Click either name above to swap in a different company.
BingEx Ltd is the larger business by last-quarter revenue ($143.2M vs $75.1M, roughly 1.9× MEDIFAST INC).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
FLX vs MED — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $143.2M | $75.1M |
| Net Profit | $3.2M | — |
| Gross Margin | 10.8% | 69.4% |
| Operating Margin | — | -10.4% |
| Net Margin | 2.2% | — |
| Revenue YoY | — | -36.9% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $-1.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $143.2M | — | ||
| Q4 25 | — | $75.1M | ||
| Q3 25 | $141.2M | $89.4M | ||
| Q2 25 | $143.0M | $105.6M | ||
| Q1 25 | $141.0M | $115.7M | ||
| Q4 24 | — | $119.0M | ||
| Q3 24 | $164.6M | $140.2M | ||
| Q2 24 | — | $168.6M |
| Q1 26 | $3.2M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $6.1M | $-2.3M | ||
| Q2 25 | $7.5M | $2.5M | ||
| Q1 25 | $27.6M | $-772.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | $3.4M | $1.1M | ||
| Q2 24 | — | $-8.2M |
| Q1 26 | 10.8% | — | ||
| Q4 25 | — | 69.4% | ||
| Q3 25 | 11.1% | 69.5% | ||
| Q2 25 | 12.0% | 72.6% | ||
| Q1 25 | 10.0% | 72.8% | ||
| Q4 24 | — | 74.1% | ||
| Q3 24 | 11.3% | 75.4% | ||
| Q2 24 | — | 73.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | -10.4% | ||
| Q3 25 | 1.4% | -4.6% | ||
| Q2 25 | 1.9% | -1.0% | ||
| Q1 25 | — | -1.1% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | 4.0% | 1.5% | ||
| Q2 24 | — | -4.7% |
| Q1 26 | 2.2% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 4.4% | -2.5% | ||
| Q2 25 | 5.2% | 2.3% | ||
| Q1 25 | 19.6% | -0.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.1% | 0.8% | ||
| Q2 24 | — | -4.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | $-1.64 | ||
| Q3 25 | — | $-0.21 | ||
| Q2 25 | — | $0.22 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | — | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $561.1M | $167.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $198.9M |
| Total Assets | $1.3B | $248.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $561.1M | — | ||
| Q4 25 | — | $167.3M | ||
| Q3 25 | $628.6M | $173.5M | ||
| Q2 25 | $499.4M | $162.7M | ||
| Q1 25 | $592.4M | $164.6M | ||
| Q4 24 | — | $162.3M | ||
| Q3 24 | $517.4M | $170.0M | ||
| Q2 24 | — | $163.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $198.9M | ||
| Q3 25 | — | $214.7M | ||
| Q2 25 | — | $216.0M | ||
| Q1 25 | — | $211.0M | ||
| Q4 24 | — | $210.1M | ||
| Q3 24 | — | $207.3M | ||
| Q2 24 | — | $205.3M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | — | $248.0M | ||
| Q3 25 | $1.3B | $268.2M | ||
| Q2 25 | $1.2B | $269.3M | ||
| Q1 25 | $1.2B | $280.0M | ||
| Q4 24 | — | $284.2M | ||
| Q3 24 | $926.8M | $291.2M | ||
| Q2 24 | — | $293.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-5.3M |
| Free Cash FlowOCF − Capex | — | $-6.6M |
| FCF MarginFCF / Revenue | — | -8.8% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $-5.3M | ||
| Q3 25 | — | $12.1M | ||
| Q2 25 | — | $-3.4M | ||
| Q1 25 | — | $3.4M | ||
| Q4 24 | — | $-4.9M | ||
| Q3 24 | — | $9.1M | ||
| Q2 24 | — | $13.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-6.6M | ||
| Q3 25 | — | $10.8M | ||
| Q2 25 | — | $-4.8M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $-7.2M | ||
| Q3 24 | — | $7.7M | ||
| Q2 24 | — | $11.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | -8.8% | ||
| Q3 25 | — | 12.0% | ||
| Q2 25 | — | -4.5% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | — | -6.1% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.36× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 8.04× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
